Objectives of Programme's Learning Outcomes

• Understand, describe, analyse and prioritise biological phenomena
• Understand basic scientific knowledge and be able to use it
• Problem-solve
• Understand the expression of biological realities in absolute or relative terms, the orders of magnitude, proportions and probability
• Control the molecular, morphological and functional approaches of normal and pathological conditions
• Understand the learning of physiological and pharmacological reasoning
• Integrate concepts from different approaches/disciplines in a complex biomedical problem
• Explain how molecular, morphological and functional modifications constitute pathological states and vice versa
• Develop reasoning skills
• Present a hypothesis and hypothetical-deductive reasoning
• Demonstrate developed interpersonal skills
• Adapt lexical and syntactic choices in communication register (everyday language, medical language or scientific terminology)
• Summarise, explain, and argue
• Submit reviews, reports and give oral presentations
• Manage resources
• Manage time
• Use basic IT and bibliographic resources.
• Manage their studies
• Locate scientific information efficiently
• Compare different sources of information
• Read, interpret, and critique a scientific article
• Be open to research and demonstrate scientific curiosity
• Show a good knowledge of scientific English
• Understand and summarise a scientific article in English

Learning Outcomes of UE

At the end of the course, the students will be able to :

- describe the current drug targets, already used in therapy or under investigations

- understand the mechanisms of action of drugs

- explain the major cell signaling pathways targeted by current and future drugs

The students will also have an overview of the new methods used in drug dicovery

UE Content: description and pedagogical relevance

1. Drug targets and cellular ionic signaling pathways
2. Drug targets and receptors of mediators (protein-kinases, guanylyl-cyclase,G-proteins, nuclear receptors)
3. Drug targets and neoronal and hormonal transmissions
4. New methods in drug discovery
 

Prior Experience

Not applicable